Evidence map›Paper›PMID 38524137›Full record

ArticleFrontiers in immunology2024

Case report: A family of atypical hemolytic uremic syndrome involving a

Yuko Tasaki, Hiroshi Tsujimoto, Tadafumi Yokoyama, Naotoshi Sugimoto, Shinji Kitajima, Hiroshi Fujii, Yoshihiko Hidaka, Noritoshi Kato, Shoichi Maruyama, Norimitsu Inoue and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuko Tasaki *Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
Hiroshi Tsujimoto *Department of Molecular Genetics, Wakayama Medical University, Wakayama, Japan.
Tadafumi YokoyamaDepartment of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
Naotoshi SugimotoDepartment of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.
Shinji KitajimaDepartment of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
Hiroshi FujiiDepartment of Nephrology and Rheumatology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Yoshihiko HidakaDepartment of Molecular Genetics, Wakayama Medical University, Wakayama, Japan.
Noritoshi KatoDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shoichi MaruyamaDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Norimitsu InoueDepartment of Molecular Genetics, Wakayama Medical University, Wakayama, Japan.
Taizo WadaDepartment of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the complement factor H (

Indexed as

Atypical Hemolytic Uremic SyndromeComplement Factor HBlood ProteinsComplement C3b Inactivator ProteinsComplement System ProteinsFemaleGene DuplicationHumansInfantMutationBlood ProteinsCFHR1 protein, humanCFHR3 protein, humanComplement C3b Inactivator ProteinsComplement Factor HComplement System Proteinsatypical hemolytic uremic syndromeCFH::CFHR1 fusion geneCFHR3-1-4-2 genes duplicationcomplement factor H-relatedfactor Hmultiplex ligation-dependent probe amplification (MLPA)

Identifiers

PMID38524137
PMCPMC10957550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.